Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9396 |
High Similarity |
NPD4118 |
Clinical (unspecified phase) |
0.8802 |
High Similarity |
NPD5658 |
Approved |
0.8316 |
Intermediate Similarity |
NPD3003 |
Approved |
0.8125 |
Intermediate Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.8103 |
Intermediate Similarity |
NPD1768 |
Approved |
0.8083 |
Intermediate Similarity |
NPD6861 |
Clinical (unspecified phase) |
0.8083 |
Intermediate Similarity |
NPD3324 |
Clinical (unspecified phase) |
0.8031 |
Intermediate Similarity |
NPD1038 |
Approved |
0.801 |
Intermediate Similarity |
NPD7194 |
Discontinued |
0.799 |
Intermediate Similarity |
NPD5902 |
Approved |
0.799 |
Intermediate Similarity |
NPD5903 |
Approved |
0.799 |
Intermediate Similarity |
NPD4795 |
Phase 2 |
0.795 |
Intermediate Similarity |
NPD8403 |
Phase 1 |
0.791 |
Intermediate Similarity |
NPD7453 |
Approved |
0.791 |
Intermediate Similarity |
NPD7452 |
Approved |
0.7879 |
Intermediate Similarity |
NPD1740 |
Approved |
0.7879 |
Intermediate Similarity |
NPD1739 |
Approved |
0.7874 |
Intermediate Similarity |
NPD6985 |
Discontinued |
0.7835 |
Intermediate Similarity |
NPD5913 |
Phase 3 |
0.7835 |
Intermediate Similarity |
NPD5912 |
Clinical (unspecified phase) |
0.7826 |
Intermediate Similarity |
NPD7823 |
Clinical (unspecified phase) |
0.7822 |
Intermediate Similarity |
NPD7222 |
Phase 2 |
0.7822 |
Intermediate Similarity |
NPD1392 |
Approved |
0.7806 |
Intermediate Similarity |
NPD4418 |
Discontinued |
0.7748 |
Intermediate Similarity |
NPD8358 |
Approved |
0.7742 |
Intermediate Similarity |
NPD1326 |
Approved |
0.7742 |
Intermediate Similarity |
NPD1325 |
Approved |
0.7739 |
Intermediate Similarity |
NPD3825 |
Phase 3 |
0.7731 |
Intermediate Similarity |
NPD7558 |
Phase 2 |
0.7725 |
Intermediate Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.772 |
Intermediate Similarity |
NPD5256 |
Discontinued |
0.7711 |
Intermediate Similarity |
NPD5669 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD1078 |
Clinical (unspecified phase) |
0.7696 |
Intermediate Similarity |
NPD4204 |
Approved |
0.7696 |
Intermediate Similarity |
NPD4203 |
Approved |
0.7692 |
Intermediate Similarity |
NPD4499 |
Approved |
0.7692 |
Intermediate Similarity |
NPD5612 |
Discontinued |
0.7685 |
Intermediate Similarity |
NPD4885 |
Approved |
0.7684 |
Intermediate Similarity |
NPD3920 |
Phase 2 |
0.7665 |
Intermediate Similarity |
NPD802 |
Phase 2 |
0.7662 |
Intermediate Similarity |
NPD4511 |
Phase 1 |
0.7638 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.763 |
Intermediate Similarity |
NPD5070 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD5930 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD5632 |
Approved |
0.761 |
Intermediate Similarity |
NPD2187 |
Approved |
0.761 |
Intermediate Similarity |
NPD2189 |
Approved |
0.7598 |
Intermediate Similarity |
NPD5530 |
Phase 1 |
0.7585 |
Intermediate Similarity |
NPD4502 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7562 |
Intermediate Similarity |
NPD4548 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD6242 |
Discontinued |
0.7538 |
Intermediate Similarity |
NPD6590 |
Discontinued |
0.7538 |
Intermediate Similarity |
NPD6491 |
Clinical (unspecified phase) |
0.7526 |
Intermediate Similarity |
NPD5065 |
Approved |
0.7525 |
Intermediate Similarity |
NPD3923 |
Approved |
0.7525 |
Intermediate Similarity |
NPD3921 |
Approved |
0.7525 |
Intermediate Similarity |
NPD3922 |
Approved |
0.7525 |
Intermediate Similarity |
NPD3924 |
Approved |
0.7524 |
Intermediate Similarity |
NPD2916 |
Discontinued |
0.7513 |
Intermediate Similarity |
NPD5680 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD5066 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3402 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD6220 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD5067 |
Phase 2 |
0.7488 |
Intermediate Similarity |
NPD2125 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD6344 |
Clinical (unspecified phase) |
0.7476 |
Intermediate Similarity |
NPD6140 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD3814 |
Phase 1 |
0.7465 |
Intermediate Similarity |
NPD5559 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD3815 |
Phase 1 |
0.7464 |
Intermediate Similarity |
NPD3816 |
Phase 1 |
0.7463 |
Intermediate Similarity |
NPD6769 |
Clinical (unspecified phase) |
0.745 |
Intermediate Similarity |
NPD3810 |
Clinical (unspecified phase) |
0.7446 |
Intermediate Similarity |
NPD7956 |
Approved |
0.7446 |
Intermediate Similarity |
NPD7955 |
Approved |
0.7437 |
Intermediate Similarity |
NPD6569 |
Phase 2 |
0.7415 |
Intermediate Similarity |
NPD6991 |
Approved |
0.7407 |
Intermediate Similarity |
NPD6872 |
Clinical (unspecified phase) |
0.7398 |
Intermediate Similarity |
NPD4889 |
Approved |
0.7385 |
Intermediate Similarity |
NPD5522 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD3397 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD6244 |
Phase 3 |
0.7368 |
Intermediate Similarity |
NPD4724 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD6243 |
Phase 3 |
0.7366 |
Intermediate Similarity |
NPD6790 |
Phase 1 |
0.7363 |
Intermediate Similarity |
NPD6251 |
Discontinued |
0.7356 |
Intermediate Similarity |
NPD7672 |
Approved |
0.7356 |
Intermediate Similarity |
NPD7671 |
Approved |
0.7347 |
Intermediate Similarity |
NPD5083 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD1322 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD6150 |
Discontinued |
0.7342 |
Intermediate Similarity |
NPD8363 |
Approved |
0.7342 |
Intermediate Similarity |
NPD8364 |
Approved |
0.7336 |
Intermediate Similarity |
NPD6503 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD6567 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7414 |
Clinical (unspecified phase) |
0.733 |
Intermediate Similarity |
NPD6494 |
Phase 2 |
0.7327 |
Intermediate Similarity |
NPD5512 |
Phase 3 |
0.7327 |
Intermediate Similarity |
NPD6550 |
Discontinued |
0.7323 |
Intermediate Similarity |
NPD2383 |
Phase 1 |
0.7321 |
Intermediate Similarity |
NPD8017 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD2921 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD8016 |
Phase 3 |
0.7315 |
Intermediate Similarity |
NPD6160 |
Clinical (unspecified phase) |
0.7313 |
Intermediate Similarity |
NPD4551 |
Phase 2 |
0.7311 |
Intermediate Similarity |
NPD5293 |
Phase 2 |
0.7295 |
Intermediate Similarity |
NPD4033 |
Approved |
0.7295 |
Intermediate Similarity |
NPD4036 |
Approved |
0.7295 |
Intermediate Similarity |
NPD31 |
Approved |
0.7295 |
Intermediate Similarity |
NPD4122 |
Approved |
0.7295 |
Intermediate Similarity |
NPD4037 |
Approved |
0.7295 |
Intermediate Similarity |
NPD4034 |
Approved |
0.7295 |
Intermediate Similarity |
NPD4039 |
Approved |
0.7295 |
Intermediate Similarity |
NPD4038 |
Approved |
0.7295 |
Intermediate Similarity |
NPD4035 |
Approved |
0.7295 |
Intermediate Similarity |
NPD32 |
Approved |
0.7288 |
Intermediate Similarity |
NPD7803 |
Approved |
0.7283 |
Intermediate Similarity |
NPD814 |
Clinical (unspecified phase) |
0.728 |
Intermediate Similarity |
NPD8365 |
Clinical (unspecified phase) |
0.7268 |
Intermediate Similarity |
NPD4501 |
Approved |
0.7268 |
Intermediate Similarity |
NPD4500 |
Approved |
0.7268 |
Intermediate Similarity |
NPD3504 |
Approved |
0.7268 |
Intermediate Similarity |
NPD3503 |
Approved |
0.726 |
Intermediate Similarity |
NPD3932 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD4987 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD6281 |
Approved |
0.725 |
Intermediate Similarity |
NPD2410 |
Phase 2 |
0.7245 |
Intermediate Similarity |
NPD3037 |
Phase 1 |
0.7243 |
Intermediate Similarity |
NPD3440 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD3478 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD3477 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD7221 |
Approved |
0.7235 |
Intermediate Similarity |
NPD1954 |
Phase 1 |
0.7235 |
Intermediate Similarity |
NPD7219 |
Approved |
0.7231 |
Intermediate Similarity |
NPD7479 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD5417 |
Clinical (unspecified phase) |
0.7227 |
Intermediate Similarity |
NPD7710 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.722 |
Intermediate Similarity |
NPD2175 |
Phase 3 |
0.722 |
Intermediate Similarity |
NPD6963 |
Approved |
0.722 |
Intermediate Similarity |
NPD2177 |
Approved |
0.722 |
Intermediate Similarity |
NPD2176 |
Approved |
0.722 |
Intermediate Similarity |
NPD6964 |
Approved |
0.7217 |
Intermediate Similarity |
NPD3330 |
Phase 1 |
0.7217 |
Intermediate Similarity |
NPD5482 |
Discontinued |
0.7215 |
Intermediate Similarity |
NPD7674 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD7675 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD7676 |
Clinical (unspecified phase) |
0.7212 |
Intermediate Similarity |
NPD3946 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD5744 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD5003 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD7729 |
Clinical (unspecified phase) |
0.7198 |
Intermediate Similarity |
NPD6208 |
Discontinued |
0.7196 |
Intermediate Similarity |
NPD1685 |
Approved |
0.7196 |
Intermediate Similarity |
NPD1684 |
Approved |
0.7195 |
Intermediate Similarity |
NPD6968 |
Phase 2 |
0.7195 |
Intermediate Similarity |
NPD6969 |
Phase 2 |
0.7193 |
Intermediate Similarity |
NPD6230 |
Discontinued |
0.7189 |
Intermediate Similarity |
NPD2882 |
Phase 1 |
0.7186 |
Intermediate Similarity |
NPD2917 |
Approved |
0.7182 |
Intermediate Similarity |
NPD3259 |
Approved |
0.7179 |
Intermediate Similarity |
NPD5670 |
Approved |
0.7177 |
Intermediate Similarity |
NPD5601 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD3763 |
Approved |
0.7171 |
Intermediate Similarity |
NPD3084 |
Phase 3 |
0.717 |
Intermediate Similarity |
NPD5936 |
Approved |
0.717 |
Intermediate Similarity |
NPD5939 |
Approved |
0.717 |
Intermediate Similarity |
NPD3570 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD7719 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD6246 |
Approved |
0.7165 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD8466 |
Approved |
0.716 |
Intermediate Similarity |
NPD8467 |
Approved |
0.716 |
Intermediate Similarity |
NPD8465 |
Approved |
0.7157 |
Intermediate Similarity |
NPD3386 |
Phase 2 |
0.715 |
Intermediate Similarity |
NPD6257 |
Clinical (unspecified phase) |
0.7149 |
Intermediate Similarity |
NPD7067 |
Approved |
0.7149 |
Intermediate Similarity |
NPD7068 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3930 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7678 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD6202 |
Discontinued |
0.7128 |
Intermediate Similarity |
NPD4354 |
Approved |
0.7123 |
Intermediate Similarity |
NPD6306 |
Phase 2 |
0.7122 |
Intermediate Similarity |
NPD4673 |
Phase 2 |
0.7121 |
Intermediate Similarity |
NPD5596 |
Phase 2 |
0.7119 |
Intermediate Similarity |
NPD7708 |
Approved |
0.7118 |
Intermediate Similarity |
NPD5483 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD4349 |
Approved |
0.7118 |
Intermediate Similarity |
NPD4350 |
Approved |
0.7117 |
Intermediate Similarity |
NPD5479 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD4952 |
Phase 3 |
0.7116 |
Intermediate Similarity |
NPD6803 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD4021 |
Phase 2 |
0.7109 |
Intermediate Similarity |
NPD5528 |
Clinical (unspecified phase) |
0.7109 |
Intermediate Similarity |
NPD5529 |
Phase 1 |
0.7103 |
Intermediate Similarity |
NPD4457 |
Phase 2 |
0.7101 |
Intermediate Similarity |
NPD4601 |
Approved |
0.7101
|
Intermediate Similarity |
NPD4600 |
Approved |